Literature DB >> 2329108

Neurotoxicity of acyclovir in end stage renal disease.

M J Gill, E Burgess.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2329108     DOI： 10.1093/jac/25.2.300

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  [Use-risk consideration of anti-infective agents from the point of view of the licensing authority].

Authors:  W Christ; B Esch
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 2.  Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  A J Wagstaff; D Faulds; K L Goa
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

3.  Population pharmacokinetics of acyclovir in children and young people with malignancy after administration of intravenous acyclovir or oral valacyclovir.

Authors:  L Zeng; C E Nath; E Y L Blair; P J Shaw; K Stephen; J W Earl; J C Coakley; A J McLachlan
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.